Recently, a study concerning OS revealed that NKILA, a tumor suppressor that interferes with the NF-κB pathway in various cancer types, has lower expression levels in OS tissues and is associated with metastasis, tumor size, and the Enneking stage. Here, NFKB1 is linked to neoplasm.